检索结果 - Tim Eisen

Refine Results
  1. 1
    Targeting Multiple Kinase Pathways: A Change In Paradigm

    Targeting Multiple Kinase Pathways: A Change In Paradigm 由 Lucy Gossage, Tim Eisen

    出版 2010
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma

    Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma 由 Tanya Ahmad, Tim Eisen

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Medical treatment of renal cancer: new horizons

    Medical treatment of renal cancer: new horizons 由 Basma Greef, Tim Eisen

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Farnesyl transferase inhibitor SCH66336 is cytostatic, pro‐apoptotic and enhances chemosensitivity to cisplatin in melanoma cells

    Farnesyl transferase inhibitor SCH66336 is cytostatic, pro‐apoptotic and enhances chemosensitivity to cisplatin in melanoma cells 由 Keiran S.M. Smalley, Tim Eisen

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Systematic review of the relationship between family history and lung cancer risk

    Systematic review of the relationship between family history and lung cancer risk 由 Athena Matakidou, Tim Eisen, Richard S. Houlston

    出版 2005
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future

    Adjuvant Therapy in Renal Cell Carcinoma—Past, Present, and Future 由 Tobias Janowitz, Sarah J. Welsh, Kamarul Zaki, Peter F.A. Mulders, Tim Eisen

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

    Genetic variation in the DNA repair genes is predictive of outcome in lung cancer 由 Athena Matakidou, Rachid El Galta, Emily L. Webb, Matthew Rudd, Helen Bridle, Tim Eisen, Richard S. Houlston

    出版 2007
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

    Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? 由 Paul J. Ross, S. Ashley, A. Norton, K. Priest, Justin S. Waters, Tim Eisen, Ian E. Smith, Mary O’Brien

    出版 2004
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Variants in the<i>GH-IGF</i>axis confer susceptibilityto lung cancer

    Variants in the<i>GH-IGF</i>axis confer susceptibilityto lung cancer 由 Matthew Rudd, Emily L. Webb, Athena Matakidou, Gabrielle S. Sellick, Richard D. Williams, Helen Bridle, Tim Eisen, Richard S. Houlston

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies

    Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies 由 Tim Eisen, Cora N. Sternberg, Caroline Robert, Peter F.A. Mulders, L Pyle, S Zbinden, Hassan Izzedine, Bernard Escudier

    出版 2012
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics

    The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics 由 Glenda Lassi, Amy E. Taylor, Nicholas J. Timpson, Paul J. Kenny, Robert J. Mather, Tim Eisen, Marcus R. Munafò

    出版 2016
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  12. 12
    Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 由 Bernard Escudier, Tim Eisen, Camillo Porta, J.-J. Patard, Vincent Khoo, Ferrán Algaba, Peter F.A. Mulders, Vesa Kataja

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

    Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer 由 Tim Eisen, Chris Boshoff, Ian Mak, Francisco Sapunar, M Vaughan, L Pyle, Stephen R.D. Johnston, Roger A’Hern, IE Smith, Martin Gore

    出版 2000
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    The treatment of advanced renal cell cancer with high-dose oral thalidomide

    The treatment of advanced renal cell cancer with high-dose oral thalidomide 由 Justin Stebbing, Charlotte Benson, Tim Eisen, L Pyle, Keiran S.M. Smalley, Helen Bridle, Ian Mak, Francisco Sapunar, Roger A’Hern, Martin Gore

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

    Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial 由 Tim Eisen, Stéphane Oudard, Cezary Szczylik, Gwénaëlle Gravis, Hans Heinzer, Richard G. Middleton, Frank Cihon, Sibyl Anderson, Sonalee Shah, Ronald M. Bukowski, Bernard Escudier

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer

    Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer 由 Siow Ming Lee, L. E. James, W. Qian, SG Spiro, Tim Eisen, N.H. Gower, D. Ferry, D. Gilligan, Peter Harper, J Prendiville, Michael P. Hocking, R.M. Rudd

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma

    A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma 由 Saiful Effendi Syafruddin, Paulo Rodrigues, Erika Vojtasova, Saroor A. Patel, M. Nazhif Zaini, Johanna Burge, Anne Y. Warren, Grant D. Stewart, Tim Eisen, Dóra Bihary, Shamith A. Samarajiwa, Sakari Vanharanta

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

    Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma 由 Charles S. Harmon, Samuel E. DePrimo, Robert A. Figlin, Gary R. Hudes, Thomas E. Hutson, M. Dror Michaelson, Sylvie Négrier, Sindy T. Kim, Xin Huang, James A. Williams, Tim Eisen, Robert J. Motzer

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts

    First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts 由 Stefanie Aeppli, Martina Schmaus, Tim Eisen, Bernard Escudier, Viktor Grünwald, James Larkin, David F. McDermott, Jan Oldenburg, Camillo Porta, Brian I. Rini, Manuela Schmidinger, Cora N. Sternberg, Christian Rothermundt, Paul Martin Putora

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design

    Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP... 由 Emma Gerety, Edward M. Lawrence, James Wason, Haixi Yan, Sarah Hilborne, John Buscombe, H.K. Cheow, Ashley Shaw, N. Bird, Kate Fife, Sarah Heard, David J. Lomas, Athena Matakidou, Dmitry Soloviev, Tim Eisen, Ferdia A. Gallagher

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: